Industry news

• IQVIA: Russia’s pharmaceutical market is growing

  12 December 2024 GxP news

  According to the latest report from IQVIA, the Russian pharmaceutical market is demonstrating sustained growth despite various challenges. In recent months, there has been a notable increase in both sales and production within the sector. Overall, the findings from IQVIA reflect a resilient pharmaceutical market in Russia, with promising potential for further development in the coming years.

• What’s next in AI’s drug discovery journey

  11 December 2024 FiercePharma

  For all the consumer-facing headlines of generative AI’s healthcare failures—some less serious, others more troubling—a contrast is unfolding in the greater pharma and biotech universe.

• Rostec delivers 108 million vaccine doses across Russian regions

  11 December 2024 GxP news

  The pharmaceutical holding “Nacimbio,” part of the Rostec State Corporation, has completed the delivery of vaccines for the planned immunization of the population in 2024, providing a total of 108 million doses to various regions in Russia. These vaccines protect against diseases such as measles, rubella, mumps, tetanus, diphtheria, whooping cough, tuberculosis, hepatitis B, and influenza.

• The State Duma will consider a bill on mobile pharmacies in 2025

  10 December 2024 GxP news

  In 2025, Russia’s State Duma will consider a bill for new mobile pharmacies. According to Sergey Leonov, the Deputy Chairman of the Committee on Health Protection, they play a crucial role in ensuring that medicines reach remote villages and towns that lack permanent pharmacies.

• Early promise for novel breast cancer immunotherapy

  09 December 2024 Catherine Eckford / European Pharmaceutical Review

  With potential “groundbreaking” results, the immunotherapy could alter the need for breast cancer patients to undertake chemotherapy, trial investigators suggest.

• By 2030, Russia aims to produce 90% of essential medicines

  09 December 2024 GxP news

  Within the framework of the national project “New Technologies for Saving Health”, it is planned to significantly increase the production of critically important medicines in Russia. As noted by the Prime Minister of the Russian Federation Mikhail Mishustin during a meeting of the Council on National Projects, by 2030 it is planned to increase the share of domestic production of vital drugs from the list of vital and essential drugs to 90%.

• The government allocated more funds for preferential loans on imported medicines and medical devices

  06 December 2024 GxP news

  The government allocated over 5 billion rubles for preferential lending to buy priority imported products. Launched in late 2022, this initiative offers affordable financing for essential foreign products. The list includes drugs containing insulin, antibiotics, various types of medical devices and other medical goods.

• RNC Pharma: Russians’ spending on medicines has reached a historic high

  06 December 2024 GxP news

  RNC Pharma reports that in October 2024, Russians’ total expenditure on pharmaceuticals reached an unprecedented 151.6 billion rubles, marking a new historical high. From January to October, the retail pharmaceutical market volume was 1.33 trillion rubles, a 16.6% increase from 2023. The main growth factor was the increase in drug prices, but the increase in household income also stimulated the transition to more expensive drugs.

• The government announced a new national project “Bioeconomics”

  05 December 2024 GxP news

  Large-scale government initiatives to develop key sectors of the Russian economy are expected soon. Russian Prime Minister Mikhail Mishustin announced that project implementation will start in early 2025 after review by the Presidential Council for Strategic Development.

• The Ministry of Health has drafted a new mechanism for supplying drugs to orphan patients

  05 December 2024 GxP news

  The Russian Ministry of Health is drafting an amendment to Federal Law to enhance medicine provision for adult patients with orphan diseases. The document states that if the regional budget lacks sufficient funds, the responsibility for provision will fall on the federal budget.